Spotlight

Expert Perspectives on the Unmet Needs in the Management of Major Depressive Disorder

Novel Delivery Systems Utilized in the Treatment of Adult ADHD

Expert Perspectives on the Clinical Management of Bipolar 1 Disorder

Major Depressive Disorder

Commentary

Couch In Crisis

Early Career Psychiatry

History of Psychiatry

Residents Corner

Cultural Corner

Film and Book Reviews

Poetry

Writers Contest

Psychiatric Practice

Burnout

Careers

Coding

Guidelines

Risk Management

Telepsychiatry

Series

Climate Change

Critical Conversations in Psychiatry

Portraits

Psychiatric Views on the Daily News

Tales From the Clinic: The Art of Psychiatry

Tales from the New Asylum

News

Around the Practice

Between the Lines

PsychView

Expert Perspectives

Case-Based Psych Perspectives

Medical World News

Payer-Provider Perspective

Slideshows

Videos

Viewpoints

Webinars

Psychiatric Times

All Publications

Partner Perspectives

Job Board

CME/CE

Partners

Clinical Scales

Conference Coverage

Conference Listing

Interactive Tools

Q&A

Quizzes

Series

Special Reports

Jim Gilligan, PhD, MBIS

home / authors / jim-gilligan-phd-mbis

Dr Gilligan is the chief science officer and interim CEO of Tryp Therapeutics.

Articles

Psychedelics for the Treatment of Binge Eating Disorder in Males

August 29th 2022

This new study is evaluating how effective psychedelics can be in the treatment of binge eating disorder.

Advertise

Editorial

Terms and Conditions

Do Not Sell My Personal Information

Contact Info

2 Clarke Drive
Cranbury, NJ 08512

609-716-7777